BCIM
VRTX icon

British Columbia Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

British Columbia Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Sell
34,971
-10,525
-23% -$4.91M 0.09% 168
2025
Q4 		$20.6M Sell
45,496
-86,351
-65% -$37.2M 0.11% 174
2025
Q3 		$51.6M Sell
131,847
-34,603
-21% -$14.5M 0.3% 67
2025
Q2 		$74.1M Buy
166,450
+17,797
+12% +$8.2M 0.43% 49
2025
Q1 		$72.1M Buy
148,653
+21,329
+17% +$9.94M 0.44% 50
2024
Q4 		$51.3M Buy
127,324
+84,266
+196% +$39.1M 0.31% 68
2024
Q3 		$20M Sell
43,058
-6,416
-13% -$3.08M 0.12% 140
2024
Q2 		$23.2M Buy
49,474
+18,605
+60% +$8.08M 0.14% 133
2024
Q1 		$12.9M Buy
30,869
+1,158
+4% +$490K 0.09% 164
2023
Q4 		$12.1M Buy
29,711
+6,290
+27% +$2.32M 0.1% 157
2023
Q3 		$8.14M Buy
23,421
+192
+0.8% +$67.1K 0.08% 187
2023
Q2 		$8.17M Buy
23,229
+264
+1% +$89K 0.08% 197
2023
Q1 		$7.24M Buy
22,965
+222
+1% +$66.6K 0.08% 216
2022
Q4 		$6.57M Sell
22,743
-2,558
-10% -$780K 0.07% 219
2022
Q3 		$7.33M Sell
25,301
-4,278
-14% -$1.23M 0.08% 203
2022
Q2 		$8.34M Sell
29,579
-9,673
-25% -$2.59M 0.08% 219
2022
Q1 		$10.2M Sell
39,252
-6,360
-14% -$1.51M 0.07% 248
2021
Q4 		$10M Sell
45,612
-2,337
-5% -$454K 0.06% 281
2021
Q3 		$8.7M Sell
47,949
-131
-0.3% -$25.6K 0.05% 304
2021
Q2 		$9.69M Buy
48,080
+5,433
+13% +$1.14M 0.06% 287
2021
Q1 		$9.16M Sell
42,647
-1,435
-3% -$315K 0.07% 257
2020
Q4 		$10.4M Sell
44,082
-940
-2% -$216K 0.07% 245
2020
Q3 		$12.3M Buy
45,022
+3,475
+8% +$959K 0.1% 174
2020
Q2 		$12.1M Buy
41,547
+13,377
+47% +$3.63M 0.12% 151
2020
Q1 		$6.7M Sell
28,170
-32,483
-54% -$7.45M 0.11% 153
2019
Q4 		$13.3M Sell
60,653
-45,603
-43% -$9.23M 0.1% 181
2019
Q3 		$18M Sell
106,256
-12,529
-11% -$2.22M 0.17% 124
2019
Q2 		$21.8M Buy
118,785
+5,692
+5% +$995K 0.19% 118
2019
Q1 		$20.8M Buy
113,093
+3,581
+3% +$661K 0.19% 123
2018
Q4 		$18.1M Buy
109,512
+25,443
+30% +$4.41M 0.16% 141
2018
Q3 		$16.2M Sell
84,069
-26,372
-24% -$4.7M 0.17% 127
2018
Q2 		$18.8M Sell
110,441
-25,272
-19% -$3.92M 0.17% 141
2018
Q1 		$22.1M Sell
135,713
-9,790
-7% -$1.6M 0.17% 143
2017
Q4 		$21.8M Sell
145,503
-56,869
-28% -$8.42M 0.15% 162
2017
Q3 		$30.8M Sell
202,372
-11,309
-5% -$1.7M 0.24% 101
2017
Q2 		$27.5M Buy
213,681
+72,525
+51% +$8.73M 0.22% 110
2017
Q1 		$15.4M Sell
141,156
-6,844
-5% -$603K 0.12% 202
2016
Q4 		$10.9M Sell
148,000
-5,419
-4% -$441K 0.1% 242
2016
Q3 		$13.4M Sell
153,419
-19,269
-11% -$1.82M 0.13% 179
2016
Q2 		$14.9M Sell
172,688
-2,314
-1% -$200K 0.13% 179
2016
Q1 		$13.9M Buy
175,002
+10,387
+6% +$940K 0.13% 184
2015
Q4 		$20.7M Sell
164,615
-16,772
-9% -$2.02M 0.2% 115
2015
Q3 		$18.9M Buy
181,387
+34,553
+24% +$4.44M 0.19% 129
2015
Q2 		$18.1M Sell
146,834
-6,226
-4% -$785K 0.17% 150
2015
Q1 		$18.1M Sell
153,060
-44,260
-22% -$5.3M 0.16% 162
2014
Q4 		$23.4M Buy
197,320
+35,041
+22% +$3.95M 0.19% 132
2014
Q3 		$18.2M Sell
162,279
-13,536
-8% -$1.29M 0.15% 172
2014
Q2 		$16.6M Sell
175,815
-20,284
-10% -$1.42M 0.13% 193
2014
Q1 		$13.9M Buy
196,099
+26,077
+15% +$2.07M 0.12% 217
2013
Q4 		$12.6M Sell
170,022
-806
-0.5% -$56.1K 0.1% 246
2013
Q3 		$13M Buy
170,828
+73,103
+75% +$5.82M 0.11% 224
2013
Q2 		$7.82M Buy
+97,725
New +$7.2M 0.06% 340

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

British Columbia Investment Management's VRTX Position: Q1 2026 in Review

British Columbia Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 23% in Q1 2026, selling an estimated $4.91M and leaving 34,971 shares worth $15.6M. The position accounts for 0.09% of the portfolio, ranked #168.

British Columbia Investment Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.1M in Q2 2025. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • British Columbia Investment Management held 34,971 shares of Vertex Pharmaceuticals worth $15.6M as of Q1 2026.
  • British Columbia Investment Management sold 10,525 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.91M.
  • Vertex Pharmaceuticals made up 0.09% of British Columbia Investment Management's portfolio in Q1 2026, its #168 holding.
  • British Columbia Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Vertex Pharmaceuticals position peaked at $74.1M in Q2 2025.
  • 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.